Dr Nasir is on the advisory board of Novo Nordisk, Novartis, Esperion, Merck Sharp and Dohme, and ER Squib and Sons; has served as a consultant for Corsera Health; and has received grants from the National Institutes of Health, Patient-Centered Outcomes Research Institute, Novartis, and Esperion. Dr Villines has served as a consultant (clinical trial advisor) for Abcentra, AngioInsight, Cleerly, HeartFlow, and Milestone; and has received grants from the National Institutes of Health.